ATLASATLAS fair value
ATLAS has no fair value for this stock today.
LENZ Therapeutics (LENZ)
LENZ Therapeutics stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$3.12▼ -0.79%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on LENZ Therapeutics in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On LENZ Therapeutics
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives LENZ Therapeutics a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $2.76 and $3.44; in 9 out of 10, between $2.27 and $4.19. Estimated annual volatility is 62%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $112M
- 52-week high
- $32.13
- 52-week low
- $3.07
- Revenue (12 months)
- $21.5M
- Gross margin
- 97.8%
- Operating margin
- -477.5%
- Net margin
- -430.3%
- Return on equity
- -59.2%
- Free cash flow (12 months)
- $-71.3M
- Beta
- 1.63
What this means
ATLAS does not publish a fair value for LENZ right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks LENZ has traded between $3.07 and $32.13. Today it is 90.3% below that high and 2% above its low.
Its beta is 1.63: it tends to move more than the market, both up and down.
About the company
LENZ Therapeutics, Inc. is a pharmaceutical and biotechnology company focused on commercializing ophthalmic treatments that improve vision. Its primary product is VIZZ, an aceclidine-based eye drop approved for the treatment of presbyopia, the age-related loss of near vision.
Want to see everything about LENZ Therapeutics?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does LENZ Therapeutics do?
LENZ Therapeutics, Inc. is a pharmaceutical and biotechnology company focused on commercializing ophthalmic treatments that improve vision. Its primary product is VIZZ, an aceclidine-based eye drop approved for the treatment of presbyopia, the age-related loss of near vision.
What is the chance LENZ goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, LENZ ends the month between $2.76 and $3.44.
How big is LENZ Therapeutics and what is its P/E ratio?
LENZ Therapeutics's market capitalization is $112M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is LENZ?
ATLAS estimates annual volatility at 62%. In a typical month, half of the outcomes end between $2.76 and $3.44.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer